HIM
IBB icon

Harbour Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Harbour Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.78M Sell
25,150
-470
-2% -$80.8K 2.47% 9
2026
Q1 		$4.33M Sell
25,620
-3,167
-11% -$542K 2.35% 9
2025
Q4 		$4.86M Sell
28,787
-8,042
-22% -$1.31M 2.58% 8
2025
Q3 		$5.32M Sell
36,829
-3,580
-9% -$489K 2.31% 8
2025
Q2 		$5.11M Sell
40,409
-740
-2% -$90.8K 2.21% 10
2025
Q1 		$5.26M Sell
41,149
-330
-0.8% -$44.7K 2.38% 7
2024
Q4 		$5.48M Sell
41,479
-625
-1% -$87.9K 2.41% 9
2024
Q3 		$6.13M Sell
42,104
-251
-0.6% -$36.3K 2.72% 6
2024
Q2 		$5.81M Buy
42,355
+1,760
+4% +$235K 2.69% 6
2024
Q1 		$5.57M Buy
40,595
+175
+0.4% +$23.9K 2.61% 7
2023
Q4 		$5.49M Sell
40,420
-300
-0.7% -$36.6K 2.87% 6
2023
Q3 		$4.99M Buy
40,720
+1,550
+4% +$197K 2.85% 8
2023
Q2 		$4.97M Sell
39,170
-525
-1% -$68.2K 2.62% 7
2023
Q1 		$5.13M Buy
39,695
+1,110
+3% +$145K 2.84% 6
2022
Q4 		$5.07M Buy
38,585
+1,350
+4% +$174K 2.92% 6
2022
Q3 		$4.36M Buy
37,235
+278
+0.8% +$34.5K 2.73% 7
2022
Q2 		$4.35M Sell
36,957
-600
-2% -$71.2K 2.62% 7
2022
Q1 		$4.89M Sell
37,557
-620
-2% -$80.8K 2.38% 9
2021
Q4 		$5.83M Sell
38,177
-565
-1% -$87.5K 2.66% 8
2021
Q3 		$6.26M Buy
38,742
+100
+0.3% +$16.8K 3.17% 7
2021
Q2 		$6.32M Hold
38,642
– – 3.17% 7
2021
Q1 		$5.82M Sell
38,642
-355
-0.9% -$56.4K 3.1% 7
2020
Q4 		$5.91M Hold
38,997
– – 3.3% 7
2020
Q3 		$5.28M Buy
38,997
+675
+2% +$91.6K 3.27% 7
2020
Q2 		$5.24M Sell
38,322
-1,554
-4% -$198K 3.66% 5
2020
Q1 		$4.3M Sell
39,876
-379
-0.9% -$43.6K 3.44% 5
2019
Q4 		$4.85M Sell
40,255
-80
-0.2% -$8.93K 3.19% 5
2019
Q3 		$4.01M Sell
40,335
-185
-0.5% -$19.4K 2.85% 5
2019
Q2 		$4.42M Sell
40,520
-150
-0.4% -$16K 3.12% 5
2019
Q1 		$4.55M Sell
40,670
-1,270
-3% -$139K 3.36% 4
2018
Q4 		$4.04M Sell
41,940
-225
-0.5% -$23.9K 3.32% 4
2018
Q3 		$5.14M Sell
42,165
-370
-0.9% -$43.6K 3.76% 3
2018
Q2 		$4.67M Sell
42,535
-1,190
-3% -$127K 3.65% 3
2018
Q1 		$4.67M Sell
43,725
-1,140
-3% -$126K 3.48% 2
2017
Q4 		$4.79M Sell
44,865
-2,700
-6% -$289K 3.37% 2
2017
Q3 		$5.29M Buy
47,565
+870
+2% +$93K 3.7% 2
2017
Q2 		$4.83M Buy
46,695
+60
+0.1% +$5.91K 3.52% 3
2017
Q1 		$4.56M Buy
46,635
+390
+0.8% +$37.3K 3.37% 3
2016
Q4 		$4.09M Buy
46,245
+255
+0.6% +$23.2K 3.11% 4
2016
Q3 		$4.44M Buy
45,990
+1,950
+4% +$186K 3.4% 3
2016
Q2 		$3.78M Buy
44,040
+2,625
+6% +$236K 2.89% 4
2016
Q1 		$3.6M Buy
41,415
+555
+1% +$49.6K 2.77% 5
2015
Q4 		$4.61M Sell
40,860
-525
-1% -$57K 3.59% 3
2015
Q3 		$4.18M Buy
41,385
+225
+0.5% +$27K 3.37% 3
2015
Q2 		$5.06M Sell
41,160
-480
-1% -$57.5K 3.8% 2
2015
Q1 		$2.13M Sell
41,640
-5,400
-11% -$596K 1.57% 22
2014
Q4 		$2.53M Hold
47,040
– – 1.59% 23
2014
Q3 		$4.29M Sell
47,040
-2,790
-6% -$245K 2.86% 4
2014
Q2 		$4.27M Sell
49,830
-1,995
-4% -$157K 2.72% 4
2014
Q1 		$4.08M Buy
51,825
+1,035
+2% +$86.2K 2.67% 7
2013
Q4 		$3.84M Sell
50,790
-930
-2% -$66K 2.57% 8
2013
Q3 		$3.61M Hold
51,720
– – 2.52% 6
2013
Q2 		$3M Buy
+51,720
New +$2.99M 2.2% 11

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Harbour Investment Management's IBB Position: Q2 2026 in Review

Harbour Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 1.8% in Q2 2026, selling an estimated $80.8K and leaving 25,150 shares worth $4.78M. The position accounts for 2.47% of the portfolio, ranked #9.

Harbour Investment Management first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.32M in Q2 2021. 223 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Harbour Investment Management held 25,150 shares of iShares Biotechnology ETF worth $4.78M as of Q2 2026.
  • Harbour Investment Management sold 470 iShares Biotechnology ETF shares in Q2 2026, an estimated $80.8K.
  • iShares Biotechnology ETF made up 2.47% of Harbour Investment Management's portfolio in Q2 2026, its #9 holding.
  • Harbour Investment Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • Harbour Investment Management's iShares Biotechnology ETF position peaked at $6.32M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Harbour Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.